Skip to main content
Daniel Vatner, MD, Endocrinology, New Haven, CT

Daniel Feller Vatner MD PhD

Diabetes, Lipid Metabolism


Assistant Professor of Medicine (Endocrinology), Yale School of Medicine; Attending Physician (Endocrinology), VA Connecticut

Join to View Full Profile
  • 20 York St# T-209New Haven, CT 06510

  • Phone+1 203-688-2259

  • Fax+1 203-688-5599

Dr. Vatner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2007 - 2010
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2013 - 2025
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats  
    Arijeet K Gattu, Varman T Samuel, Violeta Popov, Daniel F Vatner, Gary Cline, Endocrinology
  • Metformin Inhibits Gluconeogenesis via a Redox-Dependent Mechanism in Vivo  
    Kitt F Petersen, Daniel F Vatner, Gerald I Shulman, Nature

Lectures

  • 3,5-Diiodo-L-Thyronine Improves Hepatic Insulin Sensitivity but Not NAFLD in Fat-Fed Rats 
    New Haven, CT - 6/16/2014

Press Mentions

  • Targeting Hormones Could Reduce Risk of Fatty Liver Disease
    Targeting Hormones Could Reduce Risk of Fatty Liver DiseaseMarch 26th, 2025
  • How to Reverse Insulin Resistance Through Diet and Exercise
    How to Reverse Insulin Resistance Through Diet and ExerciseJuly 16th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: